ask="45.36"
ask_size="400"
average_daily_volume="1099840"
bid="43.50"
bid_size="200"
book_value="4.05"
change="+1.51"
change_from_200_day_moving_average="-1.08"
change_from_50_day_moving_average="4.15"
change_from_52_week_high="-9.79"
change_From_52_week_low="13.18"
change_in_percent="+3.44%"
close="45.36"
dividend_pay_date="N/A"
dividend_per_share="0.00"
dividend_yield="0.00"
earnings_per_share="-1.45"
ebitda="-134.59M"
eps_estimate_current_year="-1.63"
eps_estimate_next_quarter="-0.48"
eps_estimate_next_year="-1.92"
ex_dividend_date="N/A"
float_shares="85781000"
high="45.37"
high_52_weeks="55.15"
last_trade_date="2/9/2017"
last_trade_price="45.36"
last_trade_size="85972"
last_trade_time="4:00pm"
low="43.51"
low_52_weeks="32.18"
market_capitalization="3.94B"
moving_average_200_day="46.44"
moving_average_50_day="41.21"
name="Neurocrine Biosciences
Inc."
notes="N/A"
one_year_target_price="66.92"
open="43.89"
pe_ratio="N/A"
peg_ratio="0.73"
percent_change_from_200_day_moving_average="-2.32%"
percent_change_from_50_day_moving_average="+10.06%"
percent_change_from_52_week_high="-17.75%"
percent_change_from_52_week_low="+40.96%"
previous_close="43.85"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="10.83"
price_per_sales="253.95"
revenue="15.00M"
shares_outstanding="86871000"
short_ratio="3.10"
stock_exchange="NMS"
symbol="NBIX"
volume="935837"
weeks_range_52="32.18 - 55.15"
